4DMedical Ltd
ASX:4DX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
4DMedical Ltd
ASX:4DX
|
AU |
|
Pets at Home Group PLC
LSE:PETS
|
UK |
|
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
|
US |
|
Paymentus Holdings Inc
NYSE:PAY
|
US |
|
Aptose Biosciences Inc
TSX:APS
|
CA |
|
Bridgewater Bancshares Inc
NASDAQ:BWB
|
US |
|
Bureau Veritas SA
F:4BV0
|
FR |
|
P
|
Pierre et Vacances SA
F:PV6
|
FR |
|
Nuvista Energy Ltd
TSX:NVA
|
CA |
|
DHT Holdings Inc
NYSE:DHT
|
BM |
|
A
|
ALM Equity AB
STO:ALM
|
SE |
|
C
|
CSP International Fashion Group SpA
MIL:CSP
|
IT |
|
C
|
Christian Dior SE
OTC:CHDRY
|
FR |
|
T
|
TotalEnergies SE
F:TOTA
|
FR |
|
N
|
Nano One Materials Corp
SWB:LBMB
|
CA |
|
E
|
EBR Systems Inc
ASX:EBR
|
US |
|
Eupraxia Pharmaceuticals Inc
TSX:EPRX
|
CA |
Wall St Price Targets
4DX Price Targets Summary
4DMedical Ltd
According to Wall Street analysts, the average 1-year price target for
4DX is 4.62 AUD with a low forecast of 3.23 AUD and a high forecast of 6.2 AUD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4DX's stock price target?
Price Target
4.62
AUD
According to Wall Street analysts, the average 1-year price target for
4DX is 4.62 AUD with a low forecast of 3.23 AUD and a high forecast of 6.2 AUD.
What is the Revenue forecast for 4DMedical Ltd?
Projected CAGR
111%
Over the last 7 years, the compound annual growth rate for Revenue has been 33%. The projected CAGR for the next 3 years is 111%.